Pengpis N, Prueksrisakul T, Chanswangphuwana C. Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria. Med Oral Patol Oral Cir Bucal. 2023 Mar 1;28 (2):e167-73.



doi:10.4317/medoral.25629

https://dx.doi.org/doi:10.4317/medoral.25629


1.Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21:389-401.

https://doi.org/10.1016/j.bbmt.2014.12.001

PMid:25529383 PMCid:PMC4329079

2.Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am. 2008;52:79-109.

https://doi.org/10.1016/j.cden.2007.10.004

PMid:18154866 

3.Treister NS, Stevenson K, Kim H, Woo SB, Soiffer R, Cutler C. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria. Biol Blood Marrow Transplant. 2010;16:108-14.

https://doi.org/10.1016/j.bbmt.2009.09.010

PMid:19772943 

4.Lee SJ, Flowers ME. Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program. 2008:134-41.

https://doi.org/10.1182/asheducation-2008.1.134

PMid:19074071 

5.Treister NS, Cook EF Jr, Antin J, Lee SJ, Soiffer R, Woo SB. Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14:110-5.

https://doi.org/10.1016/j.bbmt.2007.06.017

PMid:18158967 

6.Mays JW, Fassil H, Edwards DA, Pavletic SZ, Bassim CW. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013;19:327-46.

https://doi.org/10.1111/odi.12028

PMid:23107104 PMCid:PMC3561479

7.Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-56.

https://doi.org/10.1016/j.bbmt.2005.09.004

PMid:16338616 

8.Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transplant. 2015;21:984-99.

https://doi.org/10.1016/j.bbmt.2015.02.025

PMid:25796139 PMCid:PMC4744804

9.Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, et al. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015;94:547-54.

https://doi.org/10.1177/0022034515570942

PMid:25740857 PMCid:PMC4485216

10.Fassil H, Bassim CW, Mays J, Edwards D, Baird K, Steinberg SM, et al. Oral chronic graft-vs.-host disease characterization using the NIH scale. J Dent Res. 2012;91:45S-51S.

https://doi.org/10.1177/0022034512450881

PMid:22699667 PMCid:PMC6728450

11.Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med. 1992;21:456-8.

https://doi.org/10.1111/j.1600-0714.1992.tb00974.x

PMid:1460584 

12.Scaraficci AC, Fernandes PM, Abreu Alves F, Filho JS, Jaguar GC. Oral manifestations of graft-versus-host disease in patients submitted to allogeneic hematopoietic stem cell transplantation: the experience of a Brazilian Cancer Center. Support Care Cancer. 2022;30:567-73.

https://doi.org/10.1007/s00520-021-06349-9

PMid:34341851 

13.Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant. 2010;16:1362-9.

https://doi.org/10.1016/j.bbmt.2010.03.023

PMid:20353829 PMCid:PMC2910178

14.Hull KM, Kerridge I, Schifter M. Long-term oral complications of allogeneic haematopoietic SCT. Bone Marrow Transplant. 2012;47:265-70.

https://doi.org/10.1038/bmt.2011.63

PMid:21441960 

15.Busca A, Locatelli F, Vai S, Dall'Omo AM, Gargiulo A, Falda M. Clinical grading of oral chronic graft-versus-host disease in 104 consecutive adult patients. Haematologica. 2005;90:567-9.

PMid:15820962

16.Kitko CL, Pidala J, Schoemans HM, Lawitschka A, Flowers ME, Cowen EW, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IIa. The 2020 clinical implementation and early diagnosis working group report. Transplant Cell Ther. 2021;27:545-57.

https://doi.org/10.1016/j.jtct.2021.03.033

PMid:33839317 PMCid:PMC8803210